Biohaven Pharmaceutical Holding Company Ltd. Soared
Tue, May 10, 2022 at 05:30 PM
Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE) jumped higher at $140, a gain of 68.4%. On Mon, May 09, 2022, BHVN:NYSE hit a New 2-Week Low of $83.14. The stock appeared on our News Catalysts scanner on Tue, May 10, 2022 at 04:00 PM in the 'MISCELLANEOUS' category. From Mon, Apr 25, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days
About Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE)
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Top 10 Gainers:
- Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE), 68.39%
- China XD Plastics Company Limited (CXDC:NASDAQ), 65.79%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 42.28%
- Appian Corporation (APPN:NASDAQ), 38.59%
- Vroom Inc. (VRM:NASDAQ), 32.41%
- MICT, Inc. (MICT:NASDAQ), 32.36%
- Amesite Inc. (AMST:NASDAQ), 28.49%
- Park-Ohio Holdings Corp. (PKOH:NASDAQ), 27.18%
- CECO Environmental Corp. (CECE:NASDAQ), 26.12%
- Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ), 25.99%